N. Jahan

4Division of Hematology/Oncology, The University of Alabama, Birmingham, AL

Papers on Lattice

Total citations

Topics

h-index

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Mahak Bhargava (1)J. Asirvatham (1)B. Stewart (1)Bohan Ning (1)

Papers (2)

Feb 18, 2026

1University of Alabama at Birmingham3w ago·also Baylor Scott and White Health, The University of Alabama, UF, University of Alabama at Birmingham

Abstract C051: Genomic and spatial immune biomarkers predictive of chemoimmunotherapy response in triple-negative breast cancer

Identifying genomic and spatial immune signatures predictive of response to neoadjuvant chemoimmunotherapy in TNBC could lead to a multimodal biomarker to guide treatment optimization.

Mahak Bhargava, J. Asirvatham, B. Stewart +10

Feb 17, 2026

3w ago·also Corcept Therapeutics, Dana Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Pfizer/Astellas +4

Abstract PS5-09-04: Tbcrc 058: a randomized phase 2 study of enzalutamide, enzalutamide with mifepristone, and treatment of physician’s choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (nct06099769)

This study will determine if enzalutamide, with or without mifepristone, improves progression-free survival compared to standard chemotherapy in patients with AR+ metastatic triple-negative or estrogen receptor-low breast cancer.

R. Nanda, Y. Chen, Y. Abdou +13

Search

N. Jahan

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Papers (2)